Integrated multi-omics analysis reveals gut dysbiosis and altered energy metabolism in Chinese ALS patients.
Level 4 - case-series / case-control
Case-control observational multi-omics study.
PubMed 42059647 · doi:10.1128/spectrum.00609-26
What was done
Integrated multi-omics profiling (gut microbiome sequencing, virome analysis, and metabolomics) in Chinese patients with amyotrophic lateral sclerosis (ALS) compared to controls to characterize compositional shifts, viral taxa, and functional metabolic pathways.
What was found
Global microbial diversity indices showed no significant differences between ALS patients and controls. Taxonomic profiling revealed significant depletion of beneficial genera (Akkermansia, Faecalibacterium) and enrichment of opportunistic/oral taxa (Escherichia, Streptococcus), along with enrichment of viral genera (Puppervirus, Donellivirus). Functional metagenomics showed upregulation of L-ascorbate (vitamin C) degradation and fatty acid biosynthesis pathways. Metabolomics identified 271 differentially expressed metabolites, including elevated inflammatory lipids (e.g., LysoPC) and tricarboxylic acid (TCA) cycle intermediates alongside depleted antioxidants. Specific numerical values, effect sizes, and p-values were not reported in the abstract.
Why it matters
This study links ALS gut dysbiosis to functional metabolic reprogramming, particularly microbial depletion of antioxidant reserves like vitamin C, identifying potential gut-brain metabolic pathways for therapeutic exploration.
Limits
The abstract does not provide the sample size, control selection details, disease duration/severity, or quantitative statistics (p-values, fold changes). The cross-sectional design demonstrates correlation rather than causality, and unmeasured confounders such as diet, dysphagia, or medication exposure cannot be ruled out from the abstract alone.
Cited by
- contradicts A study found an association between high levels of Akkermansia muciniphila in the gut and amyotrophic lateral sclerosis (ALS).